Spero

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Thursday, October 31, 2019
Finance, Financial markets, Money, Corporate finance, Economy of New York City, NASDAQ, Spero, Inducement rule, Stock

The stock options were granted as inducements material to the new employees becoming employees of Spero in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The stock options were granted as inducements material to the new employees becoming employees of Spero in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Spero (or following a bona fide period of non-employment), as an inducement material to such individuals entering into employment with Spero, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.
  • The options are subject to the terms and conditions of the 2019 Inducement Plan and the terms and conditions of a stock option agreement covering the grant.
  • Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacterial infections and rare diseases.

Specializing in Addiction Treatment, Spero Health Expands Access in Muncie

Retrieved on: 
Thursday, October 17, 2019
Mental health, Health, Clinic, Medicaid, Spero, Articles

Spero Health, a CARF-accredited organization and leader in outpatient addiction treatment, announced today the opening of an additional clinic in Indiana.

Key Points: 
  • Spero Health, a CARF-accredited organization and leader in outpatient addiction treatment, announced today the opening of an additional clinic in Indiana.
  • The Muncie Spero Health Clinic located at 3700 North Briarwood Lane will open on Tuesday, October 22nd to start seeing new patients - no appointment is necessary.
  • Spero Health accepts Indiana Medicaid and participates with select commercial insurance plans to provide individuals with a cost-effective local treatment option.
  • Spero Healths decision to open in Muncie was in response to the heavy demand for a local solution for comprehensive addiction treatment services.

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Monday, September 30, 2019
Finance, Financial markets, Money, Corporate finance, Economy of New York City, NASDAQ, Spero, Inducement rule, Stock

The stock options were granted as inducements material to the new employees becoming employees of Spero in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The stock options were granted as inducements material to the new employees becoming employees of Spero in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The 2019 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Spero (or following a bona fide period of non-employment), as an inducement material to such individuals entering into employment with Spero, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.
  • The options are subject to the terms and conditions of the 2019 Inducement Plan and the terms and conditions of a stock option agreement covering the grant.
  • Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacterial infections and rare diseases.

Spero Therapeutics Announces Second Quarter 2019 Operating Results and Provides Pipeline Update

Retrieved on: 
Thursday, August 8, 2019
Spero

We had a significant presence in June at the ASM Microbe 2019 medical conference with twenty-two presentations, and we look forward to additional data announcements from our pipeline compounds in the second half of 2019.

Key Points: 
  • We had a significant presence in June at the ASM Microbe 2019 medical conference with twenty-two presentations, and we look forward to additional data announcements from our pipeline compounds in the second half of 2019.
  • Spero continues to expect to report top-line data from the Phase 1 clinical trial in the second half of 2019.
  • Spero continues to expect to report top-line data from this trial in the second half of 2019.
  • However, while Spero may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.

Spero Foods Places in Top 3 Startups at WebSummit's Pitch Competition at Collision, the Fastest-Growing Tech Conference in North America

Retrieved on: 
Friday, May 31, 2019
Computing, Economy of California, Software, Cloud storage, Data synchronization, Dropbox, Spero, Y Combinator

"It was exhilarating to pitch at Collision," says Phaedra Randolph, Founder and CEO of Spero Foods.

Key Points: 
  • "It was exhilarating to pitch at Collision," says Phaedra Randolph, Founder and CEO of Spero Foods.
  • Right now, people just do it part of the time Spero Foods is truly what people have been waiting for," states Randolph.
  • Spero Foods has earned the title, Standout Startup of the Winter Fancy Food Show by Food Business News and 50 Women Led Startups Who Are Crushing Tech by Forbes.
  • Backed by the prestigious YCombinator, the same accelerator that incubated Dropbox and AirBnB, Spero Foods is leading a new, nondairy superfood revolution.

Spero Health Appoints Clint Cromwell as Chief Legal Officer

Retrieved on: 
Friday, April 26, 2019
Health, Mental health, Managed care, Spero

Spero Health, a CARF-accredited organization specializing in local, affordable, outpatient care for individuals suffering from substance use disorders, announced an executive leadership addition with the appointment of Clint Cromwellas Chief Legal Officer.

Key Points: 
  • Spero Health, a CARF-accredited organization specializing in local, affordable, outpatient care for individuals suffering from substance use disorders, announced an executive leadership addition with the appointment of Clint Cromwellas Chief Legal Officer.
  • View the full release here: https://www.businesswire.com/news/home/20190426005390/en/
    Spero Health, specializing in local, affordable, outpatient care for individuals suffering from substance use disorders, has appointed Clint Cromwell as Chief Legal Officer.
  • At Spero Health, Cromwell will be responsible for all legal, regulatory and compliance activities across the Spero Health organization.
  • Clint joins Spero Health at a crucial time.

Lauded by Forbes Magazine, Female Founder of Spero Foods Wows Food and Tech Industries by Creating a New Food Category with Multiple Patent-Pending Processes

Retrieved on: 
Monday, April 15, 2019
Computing, Nutrition, Spero, Digital technology, Software, Superfood, Dropbox, Food

Founded in 2016, Spero Foods is on a mission to make everyday dairy products into delicious, sustainable and nutrient-dense, healthy foods.

Key Points: 
  • Founded in 2016, Spero Foods is on a mission to make everyday dairy products into delicious, sustainable and nutrient-dense, healthy foods.
  • Phaedra Randolph, the founder of Spero Foods, healed herself from migraines, IBS, and seizures, by adopting a plant-based diet.
  • Spero Foods has earned the title, Standout Startup of the Winter Fancy Food Show by Food Business News and 50 Women Led Startups Who Are Crushing Tech by Forbes.
  • Backed by the prestigious YCombinator, the same accelerator that incubated Dropbox and AirBnB, Spero Foods is leading a new, nondairy SUPERfood revolution.

Spero Health Announces Appointment of New Chief Operating Officer

Retrieved on: 
Wednesday, March 6, 2019
Health, Mental health, General Health, Managed care, Spero

Spero Health, a CARF-accredited organization specializing in local, affordable, outpatient care for individuals suffering from substance use disorder, announced an executive leadership addition with the appointment of Edward Littlejohn as Chief Operating Officer.

Key Points: 
  • Spero Health, a CARF-accredited organization specializing in local, affordable, outpatient care for individuals suffering from substance use disorder, announced an executive leadership addition with the appointment of Edward Littlejohn as Chief Operating Officer.
  • View the full release here: https://www.businesswire.com/news/home/20190306005511/en/
    Spero Health has named Edward Littlejohn as Chief Operating Officer.
  • (Photo: Business Wire)
    Eds dynamic and multifaceted healthcare experience spans more than 20 years, including prior leadership roles as Chief Operating Officer.
  • As Chief Operating Officer, Ed will also work closely with Steve Priest, CEO, in focusing on continued operational improvement, integration and other strategic initiatives that impact the overall Spero Health community.

Spero Health Names New Indiana Medical Director and Opens First Clinic in Indianapolis

Retrieved on: 
Tuesday, January 29, 2019
Health, Hospitals, Mental health, Pharmaceutical, Managed care, Spero

View the full release here: https://www.businesswire.com/news/home/20190129005639/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20190129005639/en/
    Dr. Darrin Mangiacarne is the new Central Indiana Medical Director for Spero Health, an integrated healthcare services organization specializing in local and affordable outpatient care for individuals suffering from substance use disorder.
  • (Photo: Business Wire)
    Dr. Mangiacarne joins Spero Health with an extensive and distinguished background focused on substance use disorders, treatment and prevention.
  • Our team is fortunate to have Dr. Mangiacarne in this lead role in Indiana, said Steve Priest, CEO of Spero Health.
  • The new Indianapolis location will be the 3rd Spero Health outpatient facility in the state of Indiana.